Literature DB >> 16648842

A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells.

Joao Trindade Marques1, Thalie Devosse, Die Wang, Maryam Zamanian-Daryoush, Paul Serbinowski, Rune Hartmann, Takashi Fujita, Mark A Behlke, Bryan R G Williams.   

Abstract

Nonspecific effects triggered by small interfering RNAs (siRNAs) complicate the use of RNA interference (RNAi) to specifically downregulate gene expression. To uncover the basis of these nonspecific activities, we analyzed the effect of chemically synthesized siRNAs on mammalian double-stranded RNA (dsRNA)-activated signaling pathways. siRNAs ranging from 21 to 27 nucleotides (nt) in length activated the interferon system when they lacked 2-nt 3' overhangs, a characteristic of Dicer products. We show that the recognition of siRNAs is mediated by the RNA helicase RIG-I and that the presence of 3' overhangs impairs its ability to unwind the dsRNA substrate and activate downstream signaling to the transcription factor IRF-3. These results suggest a structural basis for discrimination between microRNAs that are endogenous Dicer products, and nonself dsRNAs such as by-products of viral replication. These findings will enable the rational design of siRNAs that avoid nonspecific effects or, alternatively, that induce bystander effects to potentially increase the efficacy of siRNA-based treatments of viral infections or cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648842     DOI: 10.1038/nbt1205

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  131 in total

Review 1.  Microparticles as autoadjuvants in the pathogenesis of SLE.

Authors:  David S Pisetsky; Peter E Lipsky
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

Review 2.  Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.

Authors:  Saurabh Singh; Ajit S Narang; Ram I Mahato
Journal:  Pharm Res       Date:  2011-10-28       Impact factor: 4.200

Review 3.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

4.  RNAimmuno: a database of the nonspecific immunological effects of RNA interference and microRNA reagents.

Authors:  Marta Olejniczak; Paulina Galka-Marciniak; Katarzyna Polak; Andrzej Fligier; Wlodzimierz J Krzyzosiak
Journal:  RNA       Date:  2012-03-12       Impact factor: 4.942

5.  Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Authors:  Jeremy M Luke; Gregory G Simon; Jonas Söderholm; John S Errett; J Thomas August; Michael Gale; Clague P Hodgson; James A Williams
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

6.  Minor-groove-modulating adenosine replacements control protein binding and RNAi activity in siRNAs.

Authors:  Hayden Peacock; Erik Fostvedt; Peter A Beal
Journal:  ACS Chem Biol       Date:  2010-10-07       Impact factor: 5.100

7.  Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific.

Authors:  Kazuo Suzuki; Takaomi Ishida; Makoto Yamagishi; Chantelle Ahlenstiel; Sanjay Swaminathan; Katharine Marks; Daniel Murray; Erin M McCartney; Michael R Beard; Marina Alexander; Damian F J Purcell; David A Cooper; Toshiki Watanabe; Anthony D Kelleher
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

8.  Differential recognition of viral RNA by RIG-I.

Authors:  Alina Baum; Adolfo García-Sastre
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

Review 9.  Activation of RIG-I-like receptor signal transduction.

Authors:  Annie M Bruns; Curt M Horvath
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-11-08       Impact factor: 8.250

Review 10.  Structural and biochemical advances in mammalian RNAi.

Authors:  Robert E Collins; Xiaodong Cheng
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.